Last reviewed · How we verify

NCT02546336

Ultrasound-Guided Hip Joint Cooled Radiofrequency Denervation

Withdrawn NA Last updated 27 February 2019
What this trial tests

NA trial testing Ultrasound-Guided Cooled Radiofrequency Hip Denervation in Hip Osteoarthritis. Withdrawn.

Timeline
1 February 2019
Primary endpoint
1 February 2019
1 February 2019

Quick facts

Lead sponsorWomen's College Hospital
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date1 February 2019
Primary completion1 February 2019
Estimated completion1 February 2019
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Women's College Hospital

Who can join

Adults 18 to 90, any sex, with Hip Osteoarthritis or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hip osteoarthritis (HOA) is a common cause of pain and disability in aging population. Conservative treatment is based on lifestyle modifications, physical therapy, analgesic and anti-inflammatory medications and intra articular injections. This Prospective Pilot Study aims at investigating the efficacy of Ultrasound-Guided Cooled Radiofrequency Hip Denervation as a treatment offered to patients with HOA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Other Women's College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02546336.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing